{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["67(1)"],"submitter":["Sabik JF"],"funding":["Medtronic"],"pubmed_abstract":["Objectives
Safety, efficacy and durability are important considerations when selecting a bioprosthesis for aortic valve replacement (AVR). This study assessed 7-year clinical outcomes and haemodynamic performance of the Avalus bioprosthesis.Methods
Patients indicated for surgical AVR were enrolled in this prospective, nonrandomized trial, conducted across 39 sites globally. The primary end-point of this analysis was freedom from surgical explant or percutaneous valve-in-valve reintervention due to structural valve deterioration (SVD) at 7 years of follow-up, determined using Kaplan-Meier (KM) analysis. We also evaluated a composite end-point of SVD and/or severe haemodynamic dysfunction requiring reintervention. Survival, valve-related safety events and haemodynamic perform"],"journal":["European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery"],"pagination":["ezae414"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC11742136"],"repository":["biostudies-literature"],"pubmed_title":["Seven-year outcomes after surgical aortic valve replacement with a stented bovine pericardial bioprosthesis in over 1100 patients: a prospective multicentre analysis."],"pmcid":["PMC11742136"],"pubmed_authors":["Baig K","Gammie J","van Leeuwen WJ","Kress D","Rao V","Baker C","Ouda A","Ito S","Kaufeld T","Duff S","Reardon MJ","Fischbein M","Klautz RJM","Lange R","Dawood M","Wu T","Brown WM","Kshettry V","Ribakove G","Bapat V","Shrestha M","Cannon M","Kuhn E","Schonhoff F","Bensari N","Falk V","Labrousse L","Kiefer P","Moritz A","Patel HJ","Sabik JF","Borger M","Tahirkheli N","Oh JK","Fukuhara S","PERIGON Investigators","Pettersson G","Walther T","Wahlers T","Kerendi F","Aldea G","Raikar G","Gunzinger R","Adams DH","Chu M","Cartier R","Koprivanac M","Dagenais F","Kappetein AP","Hagberg R","Beaver T","Weber A","Fullerton D","Carrel T","Alfieri O","Svensson L","Misfeld M","Ramlawi B","Sundt T","Ruel M","Holubec T","Takeda K","Moront MG","Steffen RJ"],"additional_accession":[]},"is_claimable":false,"name":"Seven-year outcomes after surgical aortic valve replacement with a stented bovine pericardial bioprosthesis in over 1100 patients: a prospective multicentre analysis.","description":"Objectives
Safety, efficacy and durability are important considerations when selecting a bioprosthesis for aortic valve replacement (AVR). This study assessed 7-year clinical outcomes and haemodynamic performance of the Avalus bioprosthesis.Methods
Patients indicated for surgical AVR were enrolled in this prospective, nonrandomized trial, conducted across 39 sites globally. The primary end-point of this analysis was freedom from surgical explant or percutaneous valve-in-valve reintervention due to structural valve deterioration (SVD) at 7 years of follow-up, determined using Kaplan-Meier (KM) analysis. We also evaluated a composite end-point of SVD and/or severe haemodynamic dysfunction requiring reintervention. Survival, valve-related safety events and haemodynamic perform","dates":{"release":"2024-01-01T00:00:00Z","publication":"2024 Dec","modification":"2026-06-01T20:05:50.247Z","creation":"2026-05-20T03:08:30.158Z"},"accession":"S-EPMC11742136","cross_references":{"pubmed":["39565905"],"doi":["10.1093/ejcts/ezae414"]}}